Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|15|3|196-205

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.15, Iss.3, 2015-01, pp. : 196-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?

By  

Current Pharmaceutical Design, Vol. 15, Iss. 27, 2009-09 ,pp. : 3179-3192

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma Glucose Lowering Activity of Palmatine and its Effect on Liver, Kidney and Antioxidant Enzymes Parameters in STZ Induced Diabetic Rat Model

By  

Current Bioactive Compounds, Vol. 11, Iss. 4, 2015-12 ,pp. : 256-263

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats

By Yuen Violet G   Bhanot Sanjay   Battell Mary L   Orvig Chris   McNeill John H  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 11, 2003-11 ,pp. : 1049-1055

NRC Research Press

Access to resources Recommend Favorite

The statins: lipid lowering and beyond

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Potential Therapeutic Effect of Antioxidant Therapy in Shock and Inflammation

By  

Current Medicinal Chemistry, Vol. 11, Iss. 9, 2004-05 ,pp. : 1147-1162

Bentham Science Publishers

Access to resources Recommend Favorite